Indian pharma and MedTech stakeholders are urging the government to expand the Production-Linked Incentive (PLI) scheme to cover critical APIs and reduce import duties on advanced radiotherapy equipment — aimed […]

Market research data shows that cardiac medications recorded the highest sales in India in 2025, driven by rising non-communicable diseases such as hypertension, lipid disorders, and heart failure. The cardiac […]

The 2026 Union Budget outlines a strategic shift for India’s pharmaceutical and medical device sectors, moving from high-volume, low-value production to higher-value manufacturing and innovation-led growth. The policy direction aims […]

A new Indian AI Research Organisation (IAIRO)will be established in GIFT City as a public-private initiative to advance AI R&D across sectors including healthcare. With an initial budget of ₹300 […]